000 | 01906 a2200541 4500 | ||
---|---|---|---|
005 | 20250514205248.0 | ||
264 | 0 | _c20041116 | |
008 | 200411s 0 0 eng d | ||
022 | _a0002-8177 | ||
024 | 7 |
_a10.14219/jada.archive.2004.0407 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMiller, Craig S | |
245 | 0 | 0 |
_aThe efficacy of valacyclovir in preventing recurrent herpes simplex virus infections associated with dental procedures. _h[electronic resource] |
260 |
_bJournal of the American Dental Association (1939) _cSep 2004 |
||
300 |
_a1311-8 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAcyclovir _xanalogs & derivatives |
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aDental Care |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 |
_aHerpes Labialis _xprevention & control |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aPlacebos |
650 | 0 | 4 | _aPremedication |
650 | 0 | 4 |
_aProdrugs _xtherapeutic use |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 | _aRecurrence |
650 | 0 | 4 |
_aSaliva _xvirology |
650 | 0 | 4 |
_aSimplexvirus _xisolation & purification |
650 | 0 | 4 |
_aStomatitis, Herpetic _xprevention & control |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 | _aValacyclovir |
650 | 0 | 4 |
_aValine _xanalogs & derivatives |
650 | 0 | 4 |
_aVirus Shedding _xdrug effects |
700 | 1 | _aCunningham, Larry L | |
700 | 1 | _aLindroth, John E | |
700 | 1 | _aAvdiushko, Sergei A | |
773 | 0 |
_tJournal of the American Dental Association (1939) _gvol. 135 _gno. 9 _gp. 1311-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.14219/jada.archive.2004.0407 _zAvailable from publisher's website |
999 |
_c15183108 _d15183108 |